array:24 [
  "pii" => "S1578219020300147"
  "issn" => "15782190"
  "doi" => "10.1016/j.adengl.2019.11.005"
  "estado" => "S300"
  "fechaPublicacion" => "2020-03-01"
  "aid" => "2275"
  "copyright" => "AEDV"
  "copyrightAnyo" => "2019"
  "documento" => "simple-article"
  "crossmark" => 1
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "cor"
  "cita" => "Actas Dermosifiliogr. 2020;111:87"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:1 [
    "total" => 0
  ]
  "Traduccion" => array:1 [
    "es" => array:20 [
      "pii" => "S0001731019303771"
      "issn" => "00017310"
      "doi" => "10.1016/j.ad.2019.11.001"
      "estado" => "S300"
      "fechaPublicacion" => "2020-03-01"
      "aid" => "2275"
      "copyright" => "AEDV"
      "documento" => "simple-article"
      "crossmark" => 1
      "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
      "subdocumento" => "cor"
      "cita" => "Actas Dermosifiliogr. 2020;111:87"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 37
        "formatos" => array:2 [
          "HTML" => 19
          "PDF" => 18
        ]
      ]
      "es" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Comentario editorial</span>"
        "titulo" => "Apremilast en psoriasis"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "paginas" => array:1 [
          0 => array:1 [
            "paginaInicial" => "87"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Apremilast in Psoriasis"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "A&#46; P&#233;rez Ferriols"
            "autores" => array:1 [
              0 => array:2 [
                "nombre" => "A&#46;"
                "apellidos" => "P&#233;rez Ferriols"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S1578219020300147"
          "doi" => "10.1016/j.adengl.2019.11.005"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219020300147?idApp=UINPBA000044"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731019303771?idApp=UINPBA000044"
      "url" => "/00017310/0000011100000002/v2_202009190635/S0001731019303771/v2_202009190635/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:20 [
    "pii" => "S1578219020300135"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2019.03.029"
    "estado" => "S300"
    "fechaPublicacion" => "2020-03-01"
    "aid" => "2193"
    "copyright" => "AEDV"
    "documento" => "simple-article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "cor"
    "cita" => "Actas Dermosifiliogr. 2020;111:87-8"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Commentaries</span>"
      "titulo" => "Early Syphilis&#58; New Diagnostic Approaches in a Changing Scenario"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "87"
          "paginaFinal" => "88"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "S&#237;filis precoz&#58; nuevas aproximaciones diagn&#243;sticas para un escenario cambiante"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "T&#46; Toledo Pastrana"
          "autores" => array:1 [
            0 => array:2 [
              "nombre" => "T&#46;"
              "apellidos" => "Toledo Pastrana"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0001731019301279"
        "doi" => "10.1016/j.ad.2019.03.002"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731019301279?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219020300135?idApp=UINPBA000044"
    "url" => "/15782190/0000011100000002/v1_202004140647/S1578219020300135/v1_202004140647/en/main.assets"
  ]
  "en" => array:12 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Commentaries</span>"
    "titulo" => "Apremilast in Psoriasis"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:1 [
        "paginaInicial" => "87"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "A&#46; P&#233;rez Ferriols"
        "autores" => array:1 [
          0 => array:3 [
            "nombre" => "A&#46;"
            "apellidos" => "P&#233;rez Ferriols"
            "email" => array:1 [
              0 => "perez_ampferr@gva.es"
            ]
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Servicio de Dermatolog&#237;a&#44; Hospital General Universitario&#44; Valencia&#44; Spain"
            "identificador" => "aff0005"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Apremilast en psoriasis"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">The authors present the results of a Delphi study conducted in Spain on the use of apremilast in psoriasis&#46;<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> Apremilast is a &#8220;small-molecule&#8221; oral phosphodiesterase 4 inhibitor that according to its summary of product characteristics is indicated for the treatment of psoriatic arthritis and chronic moderate to severe plaque psoriasis&#46; The position of apremilast in the current arsenal of treatments for psoriasis has been influenced by several factors&#46; First&#44; its limited effectiveness compared with other alternatives&#59; second its adverse effects&#44; which in many cases require withdrawal of treatment due to poor tolerability&#59; and last but not least&#44; its cost&#44; which is similar to that of the most effective biologic drugs available and higher than that of other biosimilars&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">The authors&#44; all experts in psoriasis&#44; chose 5 points of interest to analyze using a Delphi questionnaire&#46; After reviewing each point based on the existing literature&#44; the panel concluded that apremilast might be a treatment option for patients with a different profile to that studied in the clinical trials&#46; They highlight the need for a consensus-based definition of moderate psoriasis&#44; which is where apremilast could possibly be positioned as a treatment option preceding biologic therapy&#46; Finally&#44; they stress the need for more scientific evidence from clinical trials and real-world studies to verify the opinions expressed in this study&#46;</p></span>"
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as&#58; P&#233;rez Ferriols A&#46; Apremilast en psoriasis&#46; Actas Dermosifiliogr&#46; 2020&#59;111&#58;87&#46;</p>"
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Reference"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:1 [
            0 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Estudio Delphi para el uso de apremilast en psoriasis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "J&#46;M&#46; Carrascosa"
                            1 => "I&#46; Belinch&#243;n"
                            2 => "R&#46; Rivera"
                            3 => "M&#46; Ara"
                            4 => "M&#46; Bustinduy"
                            5 => "P&#46; Herranz"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Actas Dermosifilogr"
                        "fecha" => "2020"
                        "volumen" => "111"
                        "paginaInicial" => "115"
                        "paginaFinal" => "134"
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/15782190/0000011100000002/v1_202004140647/S1578219020300147/v1_202004140647/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "66476"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Commentaries"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/15782190/0000011100000002/v1_202004140647/S1578219020300147/v1_202004140647/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219020300147?idApp=UINPBA000044"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

Commentaries
Apremilast in Psoriasis
Apremilast en psoriasis
A. Pérez Ferriols
Servicio de Dermatología, Hospital General Universitario, Valencia, Spain
Read
3504
Times
was read the article
1528
Total PDF
1976
Total HTML
Share statistics
 array:24 [
  "pii" => "S1578219020300147"
  "issn" => "15782190"
  "doi" => "10.1016/j.adengl.2019.11.005"
  "estado" => "S300"
  "fechaPublicacion" => "2020-03-01"
  "aid" => "2275"
  "copyright" => "AEDV"
  "copyrightAnyo" => "2019"
  "documento" => "simple-article"
  "crossmark" => 1
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "cor"
  "cita" => "Actas Dermosifiliogr. 2020;111:87"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:1 [
    "total" => 0
  ]
  "Traduccion" => array:1 [
    "es" => array:20 [
      "pii" => "S0001731019303771"
      "issn" => "00017310"
      "doi" => "10.1016/j.ad.2019.11.001"
      "estado" => "S300"
      "fechaPublicacion" => "2020-03-01"
      "aid" => "2275"
      "copyright" => "AEDV"
      "documento" => "simple-article"
      "crossmark" => 1
      "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
      "subdocumento" => "cor"
      "cita" => "Actas Dermosifiliogr. 2020;111:87"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 37
        "formatos" => array:2 [
          "HTML" => 19
          "PDF" => 18
        ]
      ]
      "es" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Comentario editorial</span>"
        "titulo" => "Apremilast en psoriasis"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "paginas" => array:1 [
          0 => array:1 [
            "paginaInicial" => "87"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Apremilast in Psoriasis"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "A&#46; P&#233;rez Ferriols"
            "autores" => array:1 [
              0 => array:2 [
                "nombre" => "A&#46;"
                "apellidos" => "P&#233;rez Ferriols"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S1578219020300147"
          "doi" => "10.1016/j.adengl.2019.11.005"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219020300147?idApp=UINPBA000044"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731019303771?idApp=UINPBA000044"
      "url" => "/00017310/0000011100000002/v2_202009190635/S0001731019303771/v2_202009190635/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:20 [
    "pii" => "S1578219020300135"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2019.03.029"
    "estado" => "S300"
    "fechaPublicacion" => "2020-03-01"
    "aid" => "2193"
    "copyright" => "AEDV"
    "documento" => "simple-article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "cor"
    "cita" => "Actas Dermosifiliogr. 2020;111:87-8"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Commentaries</span>"
      "titulo" => "Early Syphilis&#58; New Diagnostic Approaches in a Changing Scenario"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "87"
          "paginaFinal" => "88"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "S&#237;filis precoz&#58; nuevas aproximaciones diagn&#243;sticas para un escenario cambiante"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "T&#46; Toledo Pastrana"
          "autores" => array:1 [
            0 => array:2 [
              "nombre" => "T&#46;"
              "apellidos" => "Toledo Pastrana"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0001731019301279"
        "doi" => "10.1016/j.ad.2019.03.002"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731019301279?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219020300135?idApp=UINPBA000044"
    "url" => "/15782190/0000011100000002/v1_202004140647/S1578219020300135/v1_202004140647/en/main.assets"
  ]
  "en" => array:12 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Commentaries</span>"
    "titulo" => "Apremilast in Psoriasis"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:1 [
        "paginaInicial" => "87"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "A&#46; P&#233;rez Ferriols"
        "autores" => array:1 [
          0 => array:3 [
            "nombre" => "A&#46;"
            "apellidos" => "P&#233;rez Ferriols"
            "email" => array:1 [
              0 => "perez_ampferr@gva.es"
            ]
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Servicio de Dermatolog&#237;a&#44; Hospital General Universitario&#44; Valencia&#44; Spain"
            "identificador" => "aff0005"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Apremilast en psoriasis"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">The authors present the results of a Delphi study conducted in Spain on the use of apremilast in psoriasis&#46;<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> Apremilast is a &#8220;small-molecule&#8221; oral phosphodiesterase 4 inhibitor that according to its summary of product characteristics is indicated for the treatment of psoriatic arthritis and chronic moderate to severe plaque psoriasis&#46; The position of apremilast in the current arsenal of treatments for psoriasis has been influenced by several factors&#46; First&#44; its limited effectiveness compared with other alternatives&#59; second its adverse effects&#44; which in many cases require withdrawal of treatment due to poor tolerability&#59; and last but not least&#44; its cost&#44; which is similar to that of the most effective biologic drugs available and higher than that of other biosimilars&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">The authors&#44; all experts in psoriasis&#44; chose 5 points of interest to analyze using a Delphi questionnaire&#46; After reviewing each point based on the existing literature&#44; the panel concluded that apremilast might be a treatment option for patients with a different profile to that studied in the clinical trials&#46; They highlight the need for a consensus-based definition of moderate psoriasis&#44; which is where apremilast could possibly be positioned as a treatment option preceding biologic therapy&#46; Finally&#44; they stress the need for more scientific evidence from clinical trials and real-world studies to verify the opinions expressed in this study&#46;</p></span>"
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as&#58; P&#233;rez Ferriols A&#46; Apremilast en psoriasis&#46; Actas Dermosifiliogr&#46; 2020&#59;111&#58;87&#46;</p>"
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Reference"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:1 [
            0 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Estudio Delphi para el uso de apremilast en psoriasis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "J&#46;M&#46; Carrascosa"
                            1 => "I&#46; Belinch&#243;n"
                            2 => "R&#46; Rivera"
                            3 => "M&#46; Ara"
                            4 => "M&#46; Bustinduy"
                            5 => "P&#46; Herranz"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Actas Dermosifilogr"
                        "fecha" => "2020"
                        "volumen" => "111"
                        "paginaInicial" => "115"
                        "paginaFinal" => "134"
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/15782190/0000011100000002/v1_202004140647/S1578219020300147/v1_202004140647/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "66476"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Commentaries"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/15782190/0000011100000002/v1_202004140647/S1578219020300147/v1_202004140647/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219020300147?idApp=UINPBA000044"
]
Article information
ISSN: 15782190
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 8 11 19
2024 October 53 52 105
2024 September 53 22 75
2024 August 82 57 139
2024 July 49 34 83
2024 June 56 21 77
2024 May 66 22 88
2024 April 61 26 87
2024 March 57 28 85
2024 February 47 25 72
2024 January 53 33 86
2023 December 40 14 54
2023 November 61 29 90
2023 October 45 12 57
2023 September 34 35 69
2023 August 33 9 42
2023 July 31 30 61
2023 June 40 25 65
2023 May 35 20 55
2023 April 25 20 45
2023 March 30 28 58
2023 February 38 22 60
2023 January 22 25 47
2022 December 37 41 78
2022 November 20 29 49
2022 October 25 15 40
2022 September 21 50 71
2022 August 26 32 58
2022 July 28 38 66
2022 June 19 29 48
2022 May 26 31 57
2022 April 31 24 55
2022 March 27 40 67
2022 February 23 21 44
2022 January 20 26 46
2021 December 24 56 80
2021 November 24 34 58
2021 October 43 52 95
2021 September 18 36 54
2021 August 19 28 47
2021 July 21 20 41
2021 June 21 22 43
2021 May 37 44 81
2021 April 71 44 115
2021 March 36 28 64
2021 February 31 21 52
2021 January 29 16 45
2020 December 27 19 46
2020 November 19 10 29
2020 October 15 7 22
2020 September 30 14 44
2020 August 28 14 42
2020 July 11 7 18
2020 June 18 22 40
2020 May 42 18 60
2020 April 76 26 102
2020 March 10 12 22
2020 February 4 2 6
Show all

Follow this link to access the full text of the article

Idiomas
Actas Dermo-Sifiliográficas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?